Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Prospectus Stories

2014-03-11 04:22:40

CHARLOTTE, N.C., March 11, 2014 /PRNewswire/ -- In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, Chiquita Brands International, Inc. confirms that as of 10 March 2014 its issued share capital comprised 46,892,044 common shares, par value $0.01 per share (the "Common Shares"). All of the Common Shares are admitted to trading on New York Stock Exchange under the ticker symbol CQB. The International Securities Identification Number for these...

2014-03-10 23:00:49

TriVascular Technologies, Inc. (TriVascular), manufacturer of the Ovation Prime® Abdominal Stent Graft System, today announced that is has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to a proposed initial public offering of shares of its common stock. Santa Rosa, CA (PRWEB) March 10, 2014 TriVascular Technologies, Inc. (TriVascular), manufacturer of the Ovation Prime® Abdominal Stent Graft System, today announced that is has...

2014-03-10 20:23:30

GUANGZHOU, China, March 10, 2014 /PRNewswire/ -- Vipshop Holdings Limited (NYSE: VIPS) (the "Company"), China's leading online discount retailer for brands, announced today the commencement of (i) a registered underwritten public offering by the Company of its convertible senior notes due 2019 (the "Notes") and (ii) a registered underwritten public offering by certain shareholders of the Company of American Depositary Shares, each representing two ordinary shares, par value $0.0001...

2014-03-10 16:32:59

- Company to present at 26th Annual ROTH Conference BRIDGEWATER, N.J., March 10, 2014 /PRNewswire/ -- CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal and infectious disease, announced today that it has closed its previously announced registered direct offering of common stock and warrant units for gross proceeds to the Company of $7.4 million. Roth Capital...

2014-03-10 16:32:57

IRVINE, Calif., March 10, 2014 /PRNewswire/ -- PRO-DEX, INC. (NasdaqCM: PDEX) today announced that a record date of March 20, 2014 (the "Record Date") has been set for the Company's planned rights offering (the "Rights Offering"). On December 17, 2013, Pro-Dex filed a registration statement on Form S-3 with the Securities and Exchange Commission (the "SEC") with respect to the Rights Offering, which was subsequently amended via Amendment No.1 to Form S-3, filed with the SEC on March...

2014-03-10 16:22:57

DALLAS, March 10, 2014 /PRNewswire/ -- Summit Midstream Partners, LP (NYSE: SMLP) today announced that it has commenced an underwritten public offering of 8,000,000 common units representing limited partner interests in SMLP, of which 5,300,000 common units are being offered by SMLP and 2,700,000 common units are being offered by Summit Midstream Partners Holdings, LLC ("SMP Holdings"), pursuant to an effective shelf registration statement on Form S-3 previously filed with the...

2014-03-10 12:26:05

BAUDETTE, Minn., March 10, 2014 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (the "Company") (NASDAQ: ANIP), today announced the closing of its previously announced underwritten public offering of 1,612,903 shares of common stock, at a price to the public of $31.00 per share and for gross proceeds of $50.0 million. The shares include 210,378 shares of common stock sold pursuant to the over-allotment option granted by ANI to the underwriters, which option was exercised in full. ANI...

2014-03-10 12:23:03

THOUSAND OAKS, Calif., March 10, 2014 /PRNewswire/ -- Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology and seed company, announced today the closing of its previously announced underwritten public offering of 20,000,000 shares of common stock at a public offering price of $1.00 per share. In connection with this offering, the underwriter exercised in full its option to purchase an additional 3,000,000 shares of common stock from the company. Total gross proceeds from the...

2014-03-10 08:29:45

XIANYANG, China, March 10, 2014 /PRNewsiwre/ -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, announced today that it entered into a securities purchase agreement (the "Securities Purchase Agreement") with certain institutional investors for the sale of 1,650,000 shares of common stock in a registered direct offering...

2014-03-07 16:23:05

SCHAUMBURG, IL, March 7, 2014 /PRNewswire/ - Catamaran Corporation ("Catamaran") (NASDAQ: CTRX) (TSX: CCT), announced today that it has agreed to sell $500 million aggregate principal amount of 4.75% senior notes due 2021 in an underwritten public offering under its effective shelf registration statement in the United States under the Securities Act of 1933 and its amended and restated base shelf prospectus in Canada under National Instrument 44-102--Shelf Distributions. The...